LDHA and posterior cortical atrophy: Since Docetaxel is a nephrotoxic chemotherapeutic agent, damage to the mesangial matrix was increased histologically in the kidney only in the PCa+Docetaxel group, while this histological damage was more in the PCa+LDH-A inhibitor + Docetaxel combined treatment group.